ESC 2019 | CONDI-2ERIC-PPCI: Final Blow Against Ischemic Pre-Conditioning in Primary Angioplasty

Remote ischemic conditioning does not offer any clinical benefit to patients with ST-segment elevation acute myocardial infarction undergoing primary angioplasty, according to this study presented on Sunday at the European Society of Cardiology Congress 2019.

Prior studies were limited and small, but this analysis seems to provide definitive evidence with regard to ischemic pre-conditioning. The way to improve must be found somewhere else.

The study randomized 5401 patients with ST-segment elevation acute myocardial infarction undergoing primary angioplasty to remote ischemic pre-conditioning (either in the ambulance or on hospital admission) or not. The pre-conditioning procedure was performed intermittently through four cycles of 5-minute inflation of a blood-pressure cuff.


Read also: ESC 2019 | THEMIS-PCI: Unlike in the Main Study, Here Ticagrelor Is Indeed Effective.


After 1 year of follow-up, there were no differences between the control and active groups regarding the primary endpoint of cardiac death or heart failure readmission. There were also no differences in the secondary endpoints (a composite of cardiac death and heart failure readmission at 30 days, and major adverse cardiac or cerebrovascular events [MACCE] at 30 days and 1 year).

Results were consistent across subgroups (by age, diabetes status, infarct location, final TIMI flow, and time elapsed from first medical contact to balloon inflation).

Other forms of ischemic pre-conditioning, such as pharmacologic compounds (exenatide and cyclosporin) or mechanical postconditioning and balloon reinflation in the coronary artery, have also failed.

Original Title: Effect of remote ischaemic conditioning on clinical outcomes in patients with STEMI undergoing primary PCI: the CONDI-2/ERIC-PPCI trial.

Reference: Botker HE. Presentado el 1 de septiembre en el ESC 2019. Paris, Francia.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...